Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

Steven R. Sarkisian, Jr.

MD

Steven R. Sarkisian, Jr., MD, is the founder and CEO of Oklahoma Eye Surgeons,
PLLC.

Dr. Sarkisian is a surgical innovator and was the first in Oklahoma to implant the
PanOptix and PanOptix Pro trifocal lenses and perform the iStent, iStent Inject,
iStent Infinite, iDose TR, Excimer Laser Trabeculotomy (ELT), Hydrus, XEN Gel Stent,
Trab-Ex, SION, and canaloplasty. He was the first in the U.S. to use the OMNI
device and the first in the world to use the TRAB360 and VISCO360 surgical
systems, the predicate devices to the OMNI. He was the first in Oklahoma and
one of the first in the USA to own and perform DSLT. Dr. Sarkisian is the
former director of the glaucoma service and fellowship at Dean McGee Eye Institute
and former Clinical Professor of Ophthalmology at the University of Oklahoma in
Oklahoma City.

He has been involved in over 50 past and current clinical trials. Due to his
involvement in the development of new glaucoma technology, he has been active in
presenting and publishing his work both in America and internationally. He coauthored the book “Minimally Invasive Glaucoma Surgery, a Practical Guide” in
2016, with a second edition to be published late 2026.

Dr. Sarkisian is listed in the Best Doctors in America, Castle and Connelly’s “Top
Doctors”, Oklahoma Super Doctors, and “America’s Top Ophthalmologists” by the
Consumers’ Research Council of America.

Born in Philadelphia, Pennsylvania, Dr. Sarkisian received his undergraduate degree
from Wheaton College in Illinois, followed by graduate work at Westminster
Theological Seminary in Philadelphia. He received his MD degree from Jefferson
Medical College and completed an ophthalmology residency at the State University
of New York Health Science Center (SUNY Downstate) in Brooklyn, New York,
followed by a fellowship in glaucoma at the Hamilton Eye Institute at the University
of Tennessee Health Science Center in Memphis.

Dr. Sarkisian currently serves on the Editorial Board of the Journal of Cataract and
Refractive Surgery, Glaucoma Today, Glaucoma Physician, and Ophthalmology
Management.

He and his wife Anne have four children and reside in Edmond, Oklahoma.

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon